Ralph Wong

2.2k total citations · 2 hit papers
8 papers, 1.5k citations indexed

About

Ralph Wong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ralph Wong has authored 8 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 1 paper in Surgery. Recurrent topics in Ralph Wong's work include Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and CAR-T cell therapy research (2 papers). Ralph Wong is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and CAR-T cell therapy research (2 papers). Ralph Wong collaborates with scholars based in Canada, United Kingdom and Australia. Ralph Wong's co-authors include Arié Figer, Stephen Clarke, Leonard B. Saltz, Tsai‐Shen Yang, Fernando Rivera, Félix Couture, Werner Scheithauer, Sheryl Koski, Mikhail Lichinitser and Florin Sirzén and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Investigational New Drugs.

In The Last Decade

Ralph Wong

8 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

2008 652 citations Jim Cassidy, Stephen Clarke et al. Journal of Clinical Oncology profile →
Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

2010 500 citations Philip A. Philip, Jacqueline Benedetti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Wong Canada	5	1.3k	400	325	220	209	8	1.5k
B. Mirtsching United States	12	1.1k 0.9×	459 1.1×	288 0.9×	131 0.6×	182 0.9×	27	1.3k
Nikolaos Ziras Greece	17	996 0.8×	369 0.9×	304 0.9×	207 0.9×	150 0.7×	55	1.2k
G. Comella Italy	21	978 0.8×	435 1.1×	190 0.6×	209 0.9×	235 1.1×	70	1.2k
Claudia Maggi Italy	21	873 0.7×	360 0.9×	301 0.9×	259 1.2×	261 1.2×	36	1.3k
Daniela Kandioler Austria	23	835 0.7×	350 0.9×	529 1.6×	351 1.6×	622 3.0×	55	1.7k
Ірина Давиденко United States	16	807 0.6×	583 1.5×	196 0.6×	284 1.3×	403 1.9×	33	1.6k
Heung-Moon Chang South Korea	25	1.4k 1.1×	908 2.3×	284 0.9×	673 3.1×	349 1.7×	79	2.1k
Lloyd K. Everson United States	16	978 0.8×	382 1.0×	195 0.6×	236 1.1×	163 0.8×	30	1.5k
Rosella Spadi Italy	13	1.1k 0.8×	489 1.2×	218 0.7×	358 1.6×	212 1.0×	28	1.4k
Jerome H. Goldschmidt United States	16	1.3k 1.1×	1.0k 2.6×	160 0.5×	132 0.6×	356 1.7×	68	1.9k

Countries citing papers authored by Ralph Wong

Since Specialization

Citations

This map shows the geographic impact of Ralph Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Wong more than expected).

Fields of papers citing papers by Ralph Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Wong. The network helps show where Ralph Wong may publish in the future.

Co-authorship network of co-authors of Ralph Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Wong. A scholar is included among the top collaborators of Ralph Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Wong. Ralph Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Buduhan, Gordon, Lawrence Tan, Bashir Bashir, et al.. (2023). Endobronchially Implanted Real-Time Electromagnetic Transponder Beacon–Guided, Respiratory-Gated SABR for Moving Lung Tumors: A Prospective Phase 1/2 Cohort Study. Advances in Radiation Oncology. 8(5). 101243–101243. 1 indexed citations

2.

Petrella, Teresa M., Richard Tozer, Karl Bélanger, et al.. (2012). Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study. Journal of Clinical Oncology. 30(27). 3396–3401. 95 indexed citations

3.

Philip, Philip A., Jacqueline Benedetti, Christopher L. Corless, et al.. (2010). Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205. Journal of Clinical Oncology. 28(22). 3605–3610. 500 indexed citations breakdown →

4.

Smylie, Michael, Joël Claveau, Raymond Taillefer, et al.. (2009). Management of Malignant Melanoma: Best Practices. Journal of Cutaneous Medicine and Surgery. 13(2). 55–73. 5 indexed citations

5.

Spano, Jean‐Philippe, Catherine Chodkiewicz, Joan Maurel, et al.. (2008). Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study. The Lancet. 371(9630). 2101–2108. 204 indexed citations

6.

Cassidy, Jim, Stephen Clarke, Eduardo Díaz‐Rubio, et al.. (2008). Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer. Journal of Clinical Oncology. 26(12). 2006–2012. 652 indexed citations breakdown →

7.

Bjarnason, Georg A., Danielle Charpentier, Ralph Wong, et al.. (2004). Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98). Investigational New Drugs. 23(1). 51–56. 1 indexed citations

8.

Winquist, Eric, et al.. (2004). A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.. PubMed. 11(6). 2445–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact